132 related articles for article (PubMed ID: 10533510)
21. Rheumatoid arthritis: an update.
Derk CT
Del Med J; 2005 Feb; 77(2):59-63. PubMed ID: 15887927
[TBL] [Abstract][Full Text] [Related]
22. [Emergence of new therapeutic agents for collagen diseases and some of the problems].
Kawai S
Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1990-6. PubMed ID: 14621590
[No Abstract] [Full Text] [Related]
23. Treatment, management, and monitoring of established rheumatoid arthritis.
Bingham CO; Miner MM
J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
[No Abstract] [Full Text] [Related]
24. Management of rheumatoid arthritis.
Handa R
Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
[TBL] [Abstract][Full Text] [Related]
25. Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?
Goodemote P; Jamieson B; Hoffman R
J Fam Pract; 2007 Nov; 56(11):933-4, 937. PubMed ID: 17976342
[No Abstract] [Full Text] [Related]
26. Anti-cytokine therapy for rheumatoid arthritis.
Maini RN; Taylor PC
Annu Rev Med; 2000; 51():207-29. PubMed ID: 10774461
[TBL] [Abstract][Full Text] [Related]
27. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
Behrens F; Koehm M; Burkhardt H
Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
[TBL] [Abstract][Full Text] [Related]
28. New therapeutic approaches for rheumatoid arthritis.
Abdelaty EM; Schumacher HR
Int J Clin Pract; 1999; 53(7):535-9. PubMed ID: 10692740
[TBL] [Abstract][Full Text] [Related]
29. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
30. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Cytokine antagonists].
Schnabel A; Gross WL
Dtsch Med Wochenschr; 2003 Jan; 128(5):201-3. PubMed ID: 12557112
[No Abstract] [Full Text] [Related]
31. Appropriate and effective management of rheumatoid arthritis.
Breedveld FC; Kalden JR
Ann Rheum Dis; 2004 Jun; 63(6):627-33. PubMed ID: 15140767
[TBL] [Abstract][Full Text] [Related]
32. New drugs for rheumatoid arthritis.
Olsen NJ; Stein CM
N Engl J Med; 2004 May; 350(21):2167-79. PubMed ID: 15152062
[No Abstract] [Full Text] [Related]
33. New treatments for rheumatoid arthritis.
Pisetsky D
Health News; 1998 Nov; 4(14):3. PubMed ID: 9825708
[No Abstract] [Full Text] [Related]
34. Emerging biologic drugs for the treatment of rheumatoid arthritis.
Puppo F; Murdaca G; Ghio M; Indiveri F
Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
[TBL] [Abstract][Full Text] [Related]
35. Disease-modifying antirheumatic drugs: enhancing efficacy by combination.
Schnabel A
Lancet; 2004 Feb; 363(9410):670-1. PubMed ID: 15001319
[No Abstract] [Full Text] [Related]
36. [Rheumatoid arthritis: current status of therapy].
El Bahri DM; Meddeb N; Sellami S
Tunis Med; 2007 Jan; 85(1):1-8. PubMed ID: 17424701
[TBL] [Abstract][Full Text] [Related]
37. Rheumatoid arthritis drugs show promise.
Mayo Clin Health Lett; 1999 Jan; 17(1):4. PubMed ID: 9919935
[No Abstract] [Full Text] [Related]
38. [New biological therapeutic options for the treatment of RE: inhibition of costimulatory molecules and blockade of Interleukin-6-interaction].
Perniok A; Rubbert-Roth A
Z Rheumatol; 2003 Oct; 62(5):433-8. PubMed ID: 14579030
[TBL] [Abstract][Full Text] [Related]
39. [Leflunomide for therapy of rheumatoid arthritis].
Nakajima A; Yamanaka H
Nihon Rinsho; 2005 Jan; 63 Suppl 1():493-7. PubMed ID: 15799405
[No Abstract] [Full Text] [Related]
40. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
Ranganath VK; Furst DE
Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
